UOB (SGX:U11)’s 1Q21 PAT beat expectations. It is seeing a strong operating rebound – especially in Singapore and North Asia – and this is likely to strengthen as economic activity opens up, we believe.
Its ASEAN exposure – where COVID is resurging – poses some near term risks, but strong provisioning and capital levels provide cushioning and potential upside from reserve write-backs down the road.
UOB’s credible execution of its digital banking strategy and regional integration should support stronger medium term growth from increased customer acquisition and North-South supply chain shifts.
We raise our UOB target price to S$29.34 from S$26.24. Upgrade to BUY.
Strong Operating Rebound
UOB's fee income rebounded 24% y-o-y on the back of wealth (+19% y-o-y) and loan/trade fees (+27%). Lower rates, increasing economic activity and supportive markets should continue to drive momentum here, in our view.
Loans expanded 5% y-o-y led by Singapore and North Asia. As markets on a firmer recovery footing, these should continue to drive growth. As vaccines progress in ASEAN, we expect incremental loan demand to firm up.
UOB’s strong cross-border integration stands to be a key regional beneficiary from North-South supply chains shifts in the medium term, in our view. Indeed, cross border income contributed a third of wholesale income. We raise 2021-2023E PPOP by 3-4% to reflect these trends.
Improving Asset Quality
1Q21 new NPL formation fell 60% potential to positively surprise on asset quality going forward. We lower UOB's 2021-23E credit charges by 2-5bps.
Raise UOB's Target Price to S$29.34. Upgrade to BUY
Our changes to assumptions raise UOB's TMRW digital bank (adding 200k customers/year) and regional integration has us increasing mid-cycle dividend growth by 1-3% in our multi-stage DDM (COE 8.6%, 3% terminal). As a result, we raise UOB's target price to S$29.34 (from S$26.24).
With 13% upside, upgrade UOB to BUY.
At our target price, UOB trades at 1.2x P/B – at its long term mean.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....